𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PLP/DM20 Expression and turnover in a transgenic mouse model of pelizaeus-merzbacher disease

✍ Scribed by Saadia A. Karim; Jennifer A. Barrie; Mailis C. Mcculloch; Paul Montague; Julia M. Edgar; Debrah L. Iden; Thomas J. Anderson; Klaus-Armin Nave; Ian R. Griffiths; Mark McLaughlin

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
950 KB
Volume
58
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The most common cause of Pelizaeus‐Merzbacher (PMD) is due to duplication of the PLP1 gene but it is unclear how increased gene dosage affects PLP turnover and causes dysmyelination. We have studied the dynamics of PLP/DM20 in a transgenic mouse model of PMD with increased gene dosage of the proteolipid protein gene (Plp1). The turnover of PLP/DM20 were investigated using an ex‐vivo brain slice system and cultured oligodendrocytes. Homozygous mice have reduced PLP translation, markedly enhanced PLP degradation, and markedly reduced incorporation of PLP into myelin. Proteasome inhibition (MG132) prevented the enhanced degradation. Numerous autophagic vesicles are present in homozygous transgenic mice that may influence protein dynamics. Surprisingly, promoting autophagy with rapamycin decreases the degradation of nascent PLP suggesting autophagic vacuoles serve as a cellular storage compartment. We suggest that there are multiple subcellular fates of PLP/DM20 when overexpressed: the vast majority being degraded by the proteasome, a proportion sequestered into autophagic vacuoles, probably fused with endolysosomes, and only a small proportion entering the myelin sheath, where its association with lipid rafts is perturbed. Transgenic oligodendrocytes have fewer membrane sheets and this phenotype is improved with siRNA‐mediated knockdown of PLP expression that promotes the formation of MBP+ myelin‐like sheets. This finding suggests that RNAi technology is in principle applicable to improve CNS myelination when compromised by PLP/DM20 overexpression. © 2010 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

PLP overexpression perturbs myelin prote
PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease
✍ Saadia A. Karim; Jennifer A. Barrie; Mailis C. McCulloch; Paul Montague; Julia M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 917 KB

## Abstract Duplication of __PLP1__, an X‐linked gene encoding the major myelin membrane protein of the human CNS, is the most frequent cause of Pelizaeus‐Merzbacher disease (PMD). Transgenic mice with extra copies of the wild type __Plp1__ gene, a valid model of PMD, also develop a dysmyelinating

Increased N-acetylaspartate in model mou
Increased N-acetylaspartate in model mouse of pelizaeus-merzbacher disease
✍ Jun-ichi Takanashi; Shigeyoshi Saito; Ichio Aoki; A. James Barkovich; Yukiko Ito 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 1008 KB

## Abstract ## Purpose: To evaluate the __N__‐acetylaspartate (NAA) and __N__‐acetylaspartylglutamate (NAAG) biochemical pathways in the brain of __myelin synthesis‐deficient__ (__msd__) mouse, a model of Pelizaeus‐Merzbacher disease (PMD). ## Materials and Methods: We performed magnetic resonan

Processing of PLP in a model of Pelizaeu
Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation
✍ Mark McLaughlin; Jennifer A. Barrie; Saadia Karim; Paul Montague; Julia M. Edgar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

## Abstract The __rumpshaker__ mutation of the X‐linked myelin proteolipid protein (__PLP1__) gene causes spastic paraplegia type 2 or a mild form of Pelizaeus‐Merzbacher disease in man. The identical mutation occurs spontaneously in mice. Both human and murine diseases are associated with dysmyeli

New variant in exon 3 of the proteolipid
New variant in exon 3 of the proteolipid protein (PLP) gene in a family with pelizaeus-merzbacher disease
✍ Pratt, Victoria M. ;Trofatter, James A. ;Larsen, Marianne B. ;Hodes, M. E. ;Dlou 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 2 views

A C --> G transversion has been found in exon 3 of the PLP gene of affected males and their mother in a single sibship with Pelizaeus-Merzbacher disease (PMD). The transversion should not result in an amino acid change in the protein but it does result in the loss of a HaeIII restriction endonucleas

Prenatal diagnosis by FISH in a family w
Prenatal diagnosis by FISH in a family with Pelizaeus–Merzbacher disease caused by duplication of the PLP gene
✍ Karen Woodward; Rodger Palmer; Kathleen Rao; Sue Malcolm 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

A diagnosis of Pelizaeus-Merzbacher disease (MIM 312080) was made in a young boy. No mutation in the coding region of the proteolipid protein (PLP) gene had been found. The boy's maternal aunt came for prenatal diagnosis when 16+ weeks pregnant and carrying a male fetus. Samples were tested for dupl

Nonsense mutation in exon 3 of the prote
Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus-Merzbacher disease
✍ Hodes, M. E.; Blank, C. A.; Pratt, V. M.; Morales, J.; Napier, J.; Dlouhy, S. R. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

We report a G→A transition at nucleotide 431 of the proteolipid protein gene (PLP) results in a nonsense codon in a family with an unusual form of Pelizaeus-Merzbacher disease (PMD). The mutation, which creates a second AluI restriction site, results in a nonsense mutation in PLP. The clinical pictu